Amarin Corp
Latest Amarin Corp News and Updates
Amarin Expects More Growth in 2021, Stock Looks Like a Buy
On Jan. 22, a Cowen analyst said that Amarin stock remains undervalued under any scenario. Is AMRN stock a good buy for investors in 2021?
Why Amarin Is Soaring in First Half of January
Amarin has been rising on rumors about pharmaceutical giant Pfizer (PFE) being interested in acquiring the company.
Amarin Stock Drops After Vascepa Appeal Hearing
Amarin stock dropped 31 percent yesterday in response to the company’s Vascepa appeal hearing.
How Much Higher Can Amarin Stock Surge?
In the November 15 premarket trading session, Amarin Corporation (AMRN) stock rose more than 7%, caused by the FDA positive decision for Vascepa.
Why Ligand Pharmaceuticals Tanked 25%
Today, US pharmaceutical firm Ligand Pharmaceuticals (LGND) fell 25% from yesterday’s closing price to a low of $98.86 for the day.
What Wall Street Recommends for Amarin after Q4 2018 Results
On February 27, Amarin (AMRN) closed at $21.18, 5.85% higher than its previous closing price, 801.28% higher than its 52-week low of $2.35, and 9.24% below its 52-week high of $23.33.
What Wall Street Recommends for Amarin and Novavax
On February 22, Amarin (AMRN) closed at $19.87, 14% higher than its previous closing price and 746% higher than its 52-week low of $2.35.
